| Literature DB >> 31366638 |
Bartłomiej Konrad Sołtysik1, Joanna Kostka2, Kamil Karolczak3, Cezary Watała3, Tomasz Kostka4.
Abstract
OBJECTIVES: The aim of the study was to determine whether cardiovascular risk factors may differ according to occupational status and whether physical activity related to total energy expenditure (PA-EE) and related to health-related behaviours (PA-HRB) is associated with common cardiovascular risk factors or metabolic syndrome in pre-elderly subjects.Entities:
Keywords: blue-collar workers; cardiovascular risk factors; metabolic syndrome; occupational status; pre-elderly; white-collar workers
Mesh:
Substances:
Year: 2019 PMID: 31366638 PMCID: PMC6677988 DOI: 10.1136/bmjopen-2018-025905
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Comparison of the major anthropometric variables, cardiovascular risk factors, diseases and drug intake between the three groups
| Variable | White-collar workers | Blue-collar workers | Unemployed subjects |
| Age (years) | 62.5 (61–64) | 62 (61–64) | 63 (63–64)*(p<0.001)† (p<0.001) |
| Education (years) | 15.5 (12.5–17) | 12 (11–13)*(p<0.001) | 12 (11–14.5) *(p<0.001) |
| BMI (kg/m²) | 27.7±3.9 | 28.2 (25.5–31.5) | 27.5 (23.9–30.8) |
| Waist circumference (cm) | 95 (87.5–102) | 97 (90–107.7)*(p=0.03) | 96 (83–105) |
| WHR | 0.9 (0.8–1.0) | 0.9±0.1*(p=0.01) | 0.9 (0.8–1.0) †(p=0.01 ) |
| TC (mg/dL) | 207.4 (178.6–233.5) | 203.5 (172.5–235.0) | 203.1 (167.1–239.3) |
| LDL (mg/dL) | 126.5 (103.3–152.1) | 130.9±38.6 | 127.4±38.8 |
| HDL (mg/dL) | 50.0 (42.5–57.6) | 46.9 (40.7–56.2) | 47.9 (39.9–59.6) |
| TG (mg/dL) | 107.7 (74.9–148.9) | 109.2 (74.5–158.7) | 116.5 (82.2–173.9) |
| Glucose (mg/dL) | 97.2 (90.1–110.3) | 101.9 (93.7–113.2) | 98.8 (90.8–111.5) |
| Uric acid (mg/dL) | 4.9±1.2 | 4.8 (4.0–5.7) | 4.8±1.4 |
| Homocysteine (µmol/L) | 14.0 (12.5–17.0) | 14.45 (12.2–16.8) | 14.8 (12.9–17.1) |
| Blood platelets (103/mm3) | 207.0±48.1 | 223.6±50.1*(p=0.02) | 214.5 (173.0–250.5) |
| SBP (mm Hg) | 133.5±17.0 | 143.4±17.0*(p<0.001) | 134.5±16.0 †(p<0.001) |
| DBP (mm Hg) | 80.0 (72.0–88.0) | 87.0±11.7*(p<0.001) | 81.9±12.4 †(p=0.001) |
| Metabolic syndrome | 63% | 69% | 63% |
| PA-EE (kcal/kg-/day) | 41.3 (37.3–48.6) | 49.6±7.6*(p<0.001) | 41.0 (37.5–44.7) †(p<0.001) |
| Stanford moderate PA-HRB I | 3.0 (1.0–4.0) | 3.0 (1.0–4.0) | 3.0 (2.0–4.0) |
| Stanford hard PA-HRB II | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| Stanford hard PA-HRB II (at least one) | 17% | 12% | 18% |
|
|
|
|
|
| HA | 50 | 53 | 54 |
| Hypercholesterolemia | 60 | 67 | 71 |
| Smoking | 20 | 26 | 23 |
| DM2 | 10 | 13 | 12 |
| MI | 5 | 4 | 6 |
| IHD | 11 | 13 | 19 |
| Stroke | 4 | 4 | 4 |
| Obesity | 30 | 33 | 32 |
| Antiplatelet drugs | 16 | 15 | 23 |
| B-blocker | 26 | 28 | 31 |
| Ca-blocker | 13 | 13 | 7 |
| Angiotensin converting enzyme inhibitor | 21 | 27 | 22 |
| Angiotensin II receptor blocker | 12 | 6 | 9 |
| Diuretics | 24 | 23 | 10 |
| Hypolipemic drugs | 21 | 26 | 30 |
| Antidiabetics | 9 | 14 | 11 |
*Statistically different from white-collar.
†Statistically different from blue-collar workers.
BMI, body mass index; DBP, diastolic blood pressure; DM2, diabetes mellitus type 2; HA, arterial hypertension; HDL-C, high-density lipoprotein cholesterol; IHD, ischaemic heart disease; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PA-EE, physical activity related to energyexpenditure; PA-HRB I, physical activity moderate health related behaviours; PA-HRB II, physical activity hard health related behaviours; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WHR, waist-hip ratio.
Associations (Spearman correlations; Mann-Whitney for metabolic syndrome) between PA indices and cardiovascular risk profile in the whole studied population and in groups according to sex
| PA | BMI | WHR | TC | TG | HDL-C | LDL-C | Glucose | UA | Hcy | SBP | DBP | Metabolic syndrome | |
| All participants N=300 | PA-EE | 0.02 (p=0.72) | 0.02 (p=0.72) | 0.03 (p=0.57) | −0.003 (p=0.95) | 0.006 (p=0.91) | 0.03 (p=0.55) | −0.02 (p=0.75) | −0.002 (p=0.97) | −0.06 (p=0.29) | 0.14 (p=0.01) | 0.06 (p=0.24) | p=0.77 |
| PA-HRBI | −0.18 (p=0.002) | −0.19 (p=0.001) | −0.003 (p=0.95) | −0.13 (p=0.02) | 0.06 (p=0.26) | 0.02 (p=0.73) | −0.19 (p=0.001) | −0.18 (p=0.001) | 0.02 (p=0.72) | −0.03 (p=0.56) | 0.04 (p=0.44) | p=0.019↓ | |
| PA-HRBII | −0.19 (p=0.001) | −0.17 (p=0.003) | 0.05 (p=0.35) | −0.15 (p=0.008) | 0.18 (p=0.001) | 0.05 (p=0.38) | −0.12 (p=0.03) | −0.10 (p=0.07) | 0.01 (p=0.77) | 0.01 (p=0.86 | (−0.05 (p=0.35) | p=0.004↓ | |
| Women N=150 | PA-EE | −0.02 (p=0.78) | 0.17 p=0.03) | 0.02 (p=0.77) | 0.02 (p=0.81) | −0.11 (p=0.19 | 0.053 (p=0.52) | −0.08 (p=0.31) | −0.06 (p=0.48) | 0.09 (p=0.25) | 0.13 (p=0.10) | 0.07 (p=0.37) | p=0.30 |
| PA-HRBI | −0.23 (p=0.004) | −0.14 (p=0.09) | 0.01 (p=0.85) | −0.16 (p=0.05) | 0.08 (p=0.28) | 0.04 (p=0.57) | −0.22 (p=0.007) | −0.28 (p=0.000) | 0.02 (p=0.81) | −0.08 (p=0.32) | 0.03 (p=0.67) | p=0.17 | |
| PA-HRBII | −0.21 (p=0.01) | −0.22 (p=0.006) | 0.05 (p=0.51) | −0.14 (p=0.92) | 0.20 (p=0.01) | 0.03 (p=0.67) | −0.17 (p=0.03) | −0.19 (p=0.01) | 0.15 (p=0.07) | −0.03 (p=0.69) | −0.01 (p=0.95) | P=0.07 | |
| Men N=150 | PA-EE | 0.07 (p=0.42) | −0.03 (p=0.71) | 0.01 (p=0.89 | −0.01 (p=0.85) | 0.09 (p=0.25) | −0.01 (p=0.84) | 0.56 (p=0.49) | 0.10 (p=0.19) | −0.19 (p=0.01) | 0.16 (p=0.05) | 0.08 (p=0.31) | P=0.47 |
| PA-HRBI | −0.12 (p=0.15) | −0.29 (p=0.000) | −0.07 (p=0.38) | −0.10 (p=0.21) | 0.001 (p=0.99) | −0.05 (p=0.57) | −0.15 (p=0.07) | −0.61 (p=0.46) | 0.04 (p=0.62) | 0.02 (p=0.80) | 0.07 (p=0.37 | p=0.11 | |
| PA-HRBII | −0.17 (p=0.04) | −0.29 (p=0.000) | 0.07 (p=0.37) | −0.16 (p=0.04) | 0.20 (p=0.01) | 0.09 (p=0.28) | −0.07 (p=0.38) | −0.04 (p=0.66) | −0.12 (p=0.13 | 0.04 (p=0.61) | −0.10 (p=0.20) | p=0.009↓ |
↓, - decreases incidence of metabolic syndrome.
BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; Hcy, homocysteine; LDL-C, low-density lipoprotein cholesterol; PA-EE, physical activity related to energy expenditure; PA-HRB I, physical activity moderate health related behaviours; PA-HRB II, physical activity hard health related behaviours. No correlation for PLT count was found; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, uric acid; WHR, waist-hip ratio.
Independent variables selected in multivariate analyses influencing cardiovascular risk profile in the whole studied population (n=300)
| BMI | WHR | TC | TG | HDL-C | LDL-C | Glucose | UA | Hcy | SBP | DBP | Metabolic syndrome | |
| PA | PA-HRBI↓ PA-HRBII↓ | PA-HRBI↓ | PA-HRBII↓ | PA-HRBII↑ | PA-HRBI↓ | PA-HRBI↓ | PA-HRBI↓ | |||||
| Occupational status | White-collar↔ | White-collar ↓ | White-collar ↓ | |||||||||
| Sex | Female sex↓ | Female sex↑ | Female sex↑ | Female sex↑ | Female sex↓ | Female sex↓ | Female sex↑ | Female sex↓ | Female sex↓ | Female sex↓ | ||
| Smoking and drugs | Hypolipemic drugs ↓ | Smoking↑ | Hypolipemic drugs ↓ | Antidiabetics ↓ |
↑, increase; ↓, decrease; ↔, no difference.
ACEI, angiotensin converting enzyme inhibitors; BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; Hcy, homocysteine; LDL-C, low-density lipoprotein cholesterol; PA-HRB I, physical activity moderate health-related behaviours; PA-HRB II, physical activity hard health-related behaviours; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, uric acid; WHR, waist-hip ratio.
Comparison of the major anthropometric variables, cardiovascular risk factors, diseases and drug intake between the three groups of women
| Variable | White-collar female workers | Blue-collar female workers | Unemployed females |
| Age (years) | 62 (61–64) | 62 (61–63) | 63 (63–64) *(p<0.001) †(p<0.001) |
| Education (years) | 14.5 (12–17) | 13 (11–14) *(p<0.001) | 13 (12–16) *(p=0.04) |
| BMI (kg/m²) | 27.6±4.4 | 28.24 (25.3–31.3) | 27.0 (23.4–31.6) |
| Waist circumference (cm) | 88.5 (81–97) | 93 (86–100) | 85.5 (77.5–100) |
| WHR | 0.8±0.1 | 0.9±0.1 *(p=0.01) | 0.8±0.1 †(p<0.001) |
| TC (mg/dL) | 214.5 (185.0–249.0) | 221.3±51.5 | 216.4±44.3 |
| LDL (mg/dL) | 140.4 (104.9–156.3) | 143.7±41.1 | 134.5±41.9 |
| HDL(mg/dL) | 52.9 (45.4–69.0) | 51.2 (45.2–51.9) | 57.0±14.6 |
| TG (mg/dL) | 107.9 (78.6–159.8) | 114.7 (74.0–158.7) | 113.0 (76.8–159.4) |
| Glucose (mg/dL) | 95.8 (89.0–105.6) | 101.6 (92.6–108.9) | 94.7 (88.7–106.9) |
| Uric acid (mg/dL) | 4.4±1.2 | 4.3 (3.9–5.1) | 3.8 (3.2–4.9) †(p=0.01) |
| Homocysteine (µmol/L) | 13.3 (11.9–16.2) | 14.25 (12.1–15.9) | 14.3 (12.7–16.0) |
| Blood platelets (103/mm3) | 220.1±45.9 | 246.2±46.7 *(p=0.005) | 224.5 (196–256) |
| SBP (mm Hg) | 130.5±15.48 | 140.5±15.1 *(p=0.003) | 133.1±13.2 †(p=0.01) |
| DBP (mm Hg) | 78.2±11.6 | 84.6±9.9 *(p=0.004) | 80.5±11.9 |
| Metabolic syndrome | 27 (54%) | 30 (60%) | 22 (44%) |
| PA-EE (kcal/kg/ day) | 44.1 (38.7–48.7) | 50.52±7.33 *(p<0.001) | 41.0 (38.1–43.8) †(p<0.001) |
| Stanford moderate PA-HRB I | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) |
| Stanford hard PA-HRB II | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| Stanford hard PA-HRB II (at least one) | 8 (16%) | 5 (10%) | 10 (20%) |
|
|
|
|
|
| HA | 24 | 23 | 21 |
| Hypercholesterolemia | 34 | 35 | 36 |
| Smoking | 13 | 12 | 6 |
| DM2 | 4 | 7 | 5 |
| MI | 1 | 0 | 1 |
| IHD | 6 | 5 | 6 |
| Stroke | 3 | 2 | 1 |
| Obesity | 17 | 16 | 14 |
| Antiplatelet drugs | 6 | 9 | 13 |
| B-blocker | 15 | 14 | 15 |
| Ca-blocker | 5 | 5 | 2 |
| Angiotensin converting enzyme inhibitor | 10 | 13 | 10 |
| Angiotensin II receptor blocker | 10 | 3 | 4 |
| Diuretics | 12 | 12 | 5 |
| Hypolipemic drugs | 9 | 12 | 13 |
| Antidiabetics | 3 | 7 | 5 |
*Statistically different from white-collar.
†Statistically different from blue-collar workers.
BMI, body mass index; DBP, diastolic blood pressure; DM2, diabetes mellitus type 2; HA, arterial hypertension; HDL-C, high-density lipoprotein cholesterol; IHD, ischaemic heart disease; LDL-C, low-density lipoprotein cholesterol; PA-EE, physical activity related to energy expenditure; PA-HRB I, physical activity moderate health-related behaviours; PA-HRB II, physical activity hard health-related behaviours; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WHR, waist-hip ratio.
Comparison of the major anthropometric variables, cardiovascular risk factors, diseases and drug intake between the three groups of men
| Variable | White-collar male workers | Blue-collar male workers | Unemployed men |
| Age (years) | 63 (61–64) | 63 (61–65) | 63 (63–65) |
| Education (years) | 16 (13–17) | 12.0 (11.0–13.0) *(p<0.001) | 12.0 (11.0–13.0) *(p<0.001) |
| BMI (kg/m²) | 27.8±3.5 | 28.0 (25.5–32.1) | 27.7±4.3 |
| Waist circumference (cm) | 98.5 (94–106) | 103 (95–114.5) | 102 (94–109.5) |
| WHR | 1.0±0.1 | 1.0±0.1 | 1.0±0.1 |
| TC (mg/dL) | 197.8±35.8 | 190.3±37.4 | 192.5±40.1 |
| LDL (mg/dL) | 124.9±30.8 | 117.9±31.3 | 120.1±34.1 |
| HDL (mg/dL) | 48.2 (39.3–54.0) | 44.7 (39.2–52.5) | 41.5 (36.6–48.4) *(p=0.03) |
| TG (mg/dL) | 104.4 (70.9–139.3) | 106.0 (74.9–158.6) | 123.1 (88.3–188.5) *(p=0.01) |
| Glucose (mg/dL) | 99.2 (92.2–112.4) | 102.3 (96.1–114.7) | 102.3 (93.9–114.1) |
| Uric acid (mg/dL) | 5.3±1.0 | 5.3±1.2 | 5.5±1.1 |
| Homocysteine (µmol/L) | 16.0±3.7 | 14.7 (12.7–17.5) | 15.9±3.9 |
| Blood platelets (103/mm3) | 193.7±47.0 | 201.5±43.3 | 187.5 (165.0–237.0) |
| SBP (mm Hg) | 135 (125–145) | 146.3±18.4 *(p=0.002) | 135.9±18.3 †(p=0.008) |
| DBP (mm Hg) | 82 (75–93) | 89.4±12.9 *(p=0.03) | 83.2±12.8 †(p=0.01) |
| Metabolic syndrome | 36 (72%) | 39 (78%) | 41 (82%) |
| PA-EE (kcal/kg/ day) | 40.0 (36.6–48.1) | 48.7±7.9 *(p<0.001) | 40.9 (37.3–45.0) † (p<0.001) |
| Stanford moderate PA-HRB I | 3.0 (1.0–4.0) | 2.5 (1.0–4.0) | 2.5 (1.0–4.0) |
| Stanford hard PA-HRB II | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
| Stanford hard PA-HRB II (at least one) | 9 (18%) | 7 (14%) | 8 (16%) |
|
|
|
|
|
| HA | 26 | 30 | 33 |
| Hypercholesterolemia | 26 | 32 | 35 |
| Smoking | 7 | 14 | 17 |
| DM2 | 6 | 6 | 7 |
| MI | 4 | 4 | 5 |
| IHD | 5 | 8 | 13 |
| Stroke | 1 | 2 | 3 |
| Obesity | 13 | 17 | 18 |
| Antiplatelet drugs | 10 | 6 | 10 |
| B-blocker | 11 | 14 | 16 |
| Ca-blocker | 8 | 8 | 5 |
| Angiotensin converting enzyme inhibitor | 11 | 14 | 12 |
| Angiotensin II receptor blocker | 2 | 3 | 5 |
| Diuretics | 12 | 11 | 5 |
| Hypolipemic drugs | 12 | 14 | 17 |
| Antidiabetics | 6 | 7 | 6 |
*Statistically different from white-collar.
†Statistically different from blue-collar workers.
BMI, body mass index; DBP, diastolic blood pressure; DM2, diabetes mellitus type 2; HA, arterial hypertension; HDL-C, high-density lipoprotein cholesterol; PA-HRB I, physical activity moderate health-related behaviours; IHD, ischaemic heart disease; PA-HRB II, physical activity hard health-related behaviours; LDL-C, low-density lipoprotein cholesterol; PA-EE, physical activity related to energy expenditure; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WHR, waist-hip ratio.